Which statement about treatment for meconium aspiration syndrome (MAS) is true?

Enhance your readiness for the MEDNAX Neonatal Nurse Practitioner Exam. Utilize flashcards, multiple-choice questions, and detailed explanations. Equip yourself for success!

Multiple Choice

Which statement about treatment for meconium aspiration syndrome (MAS) is true?

Explanation:
Meconium exposure disrupts lung function by causing airway plugging and surfactant inactivation, so the main focus of treatment is to restore effective gas exchange and lung compliance. In severe MAS, giving exogenous surfactant can markedly improve oxygenation and lung mechanics by replenishing deficient surfactant and helping reopen collapsed alveoli. Antibiotics are not automatically required for all MAS cases; they’re added only if there’s concern for concurrent infection or sepsis. Steroids aren’t routinely used for MAS, and oxygenation should be carefully managed to avoid toxicity while ensuring adequate tissue oxygen delivery. Therefore, the statement that exogenous surfactant should be considered in severe MAS is true.

Meconium exposure disrupts lung function by causing airway plugging and surfactant inactivation, so the main focus of treatment is to restore effective gas exchange and lung compliance. In severe MAS, giving exogenous surfactant can markedly improve oxygenation and lung mechanics by replenishing deficient surfactant and helping reopen collapsed alveoli. Antibiotics are not automatically required for all MAS cases; they’re added only if there’s concern for concurrent infection or sepsis. Steroids aren’t routinely used for MAS, and oxygenation should be carefully managed to avoid toxicity while ensuring adequate tissue oxygen delivery. Therefore, the statement that exogenous surfactant should be considered in severe MAS is true.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy